Evidence map›Paper›PMID 14694097›Full record

ArticleJournal of virology2004

Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages.

Richard Lu, Noriko Nakajima, Wolfgang Hofmann, Monsef Benkirane, Kuan-Teh Jeang, Joseph Sodroski, Alan Engelman, Kuan Teh-Jeang

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Integration-deficient lentiviral vectors: a slow coming of age.Molecular therapy : the journal of the American Society of Gene Therapy · 2009
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

  • Erratum issued
    Teh-Jeang Kuan [corrected to Jeang Kuan-Teh]
5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Richard LuDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Noriko Nakajima
Wolfgang Hofmann
Monsef Benkirane
Kuan-Teh Jeang
Joseph Sodroski
Alan Engelman
Kuan Teh-Jeang
Dana-Farber Cancer Institute · USHarvard University · USNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

DFCI-BIDMC-CH CENTER FOR AIDS RESEARCHP30AI028691 · NIAID · DANA-FARBER CANCER INSTITUTE · PI SODROSKI, JOSEPH G · 1989 to 2003
$6.2M
MOLECULAR MECHANISMS OF HUMAN RETROVIRUS TRANS-REGULATORY PROTEINSZ01AI000547 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI JEANG, KUAN-TEH · 1989 to 2008
$2.8M
MECHANISM OF NON-INTEGRASE-MEDIATED HIV-1 REPLICATIONR01AI045313 · NIAID · DANA-FARBER CANCER INSTITUTE · PI ENGELMAN, ALAN N. · 1999 to 2001
$434k
MECHANISM OF NONINTEGRASE MEDIATED HIV1 REPLICATIONR21AI045313 · NIAID · DANA-FARBER CANCER INSTITUTE · PI ENGELMAN, ALAN N. · 1999 to 1999
–
NIAID NIH HHS AI28691NIAID NIH HHS AI45313NIAID NIH HHS P30 AI028691
6 · The paper itself

Abstract

Integrase function is required for retroviral replication in most instances. Although certain permissive T-cell lines support human immunodeficiency virus type 1 (HIV-1) replication in the absence of functional integrase, most cell lines and primary human cells are nonpermissive for integrase mutant growth. Since unintegrated retroviral DNA is lost from cells following cell division, we investigated whether incorporating a functional origin of DNA replication into integrase mutant HIV-1 might overcome the block to efficient gene expression and replication in nonpermissive T-cell lines and primary cells. Whereas the Epstein-Barr virus (EBV) origin (oriP) did little to augment expression from an integrase mutant reporter virus in EBV nuclear antigen 1-expressing cells, simian virus 40 (SV40) oriT dramatically enhanced integrase mutant infectivity in T-antigen (Tag)-expressing cells. Incorporating oriT into the nef position of a full-length, integrase-defective virus strain yielded efficient replication in Tag-expressing nonpermissive Jurkat T cells without reversion to an integration-competent genotype. Adding Tag to integrase mutant-oriT viruses yielded 11.3-kb SV40-HIV chimeras that replicated in Jurkat cells and primary monocyte-derived macrophages. Real-time quantitative PCR analyses of Jurkat cell infections revealed that amplified copies of unintegrated DNA likely contributed to SV40-HIV integrase mutant replication. SV40-based HIV-1 integrase mutant replication in otherwise nonpermissive cells suggests alternative approaches to standard integrase-mediated retroviral gene transfer strategies.

Indexed as

MutationVirus ReplicationAntigens, Polyomavirus TransformingCell LineHIV-1HIV IntegraseHumansJurkat CellsMacrophagesMonocytesRecombinant Fusion ProteinsReplication OriginSimian virus 40T-LymphocytesVirus IntegrationAntigens, Polyomavirus TransformingHIV IntegraseRecombinant Fusion Proteins

Identifiers

PMID14694097
PMCPMC368853
OpenAlexW1994056131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.